Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors

This study demonstrates the safety and feasibility of ICI treatment in aggressive PitNETs. We also identified MMRd and temozolomide hypermutation as potential biomarkers of response to ICI. Overall, our data suggest that ICIs might provide an additional treatment option for PitNET; this should be evaluated more broadly in future studies.

Authors

Institutions

Publication Details

Journal
The Journal of Clinical Endocrinology & Metabolism
Published
2025-03-20
DOI
https://doi.org/10.1210/clinem/dgaf178
Citations
8
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
10.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors

Soma Sengupta, Andrew Lin, Eliza B. Geer, Robert J. Young et al.
8 citations
The Journal of Clinical Endocrinology & Metabolism
Pituitary Gland Disorders and Treatments
10.36
article

Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors

Soma Sengupta, Andrew Lin, Eliza B. Geer, Robert J. Young, Anna F. Piotrowski, Odelia Cooper, Ingo K. Mellinghoff, Igor T. Gavrilovic, Mark T.A. Donoghue, Bernard Goichot, Rajiv Magge, Thomas Kaley, Marc K. Rosenblum, Vasilisa A. Rudneva, Nazanin Majd, Viviane Tabar, Adam Newton
article en
8 citations

Abstract

This study demonstrates the safety and feasibility of ICI treatment in aggressive PitNETs. We also identified MMRd and temozolomide hypermutation as potential biomarkers of response to ICI. Overall, our data suggest that ICIs might provide an additional treatment option for PitNET; this should be evaluated more broadly in future studies.

The Journal of Clinical Endocrinology & MetabolismVol. 110(11)
University of North Carolina at Chapel Hill (US), Cedars-Sinai Medical Center (US), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Cornell University (US), Hôpitaux Universitaires de Strasbourg (FR), Molecular Oncology (United States) (US), UNC Lineberger Comprehensive Cancer Center
Good health and well-being
Openalex Percentile: Top 2%
Pituitary Gland Disorders and Treatments
10.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.